Clinical Trials Logo

Portal Hypertension clinical trials

View clinical trials related to Portal Hypertension.

Filter by:

NCT ID: NCT00331188 Completed - Portal Hypertension Clinical Trials

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

Start date: May 2006
Phase: Phase 3
Study type: Interventional

The main objective of this study is to determine the efficacy of early administration of Sanvar® in combination with endoscopic treatment for the control of acute variceal bleeding.

NCT ID: NCT00163982 Recruiting - Portal Hypertension Clinical Trials

Vasoactive Peptides in Portal Pressure

Start date: n/a
Phase: N/A
Study type: Interventional

This study is looking at the detection of vasoactive peptides in portal hypertension.

NCT ID: NCT00163631 Completed - Portal Hypertension Clinical Trials

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

Start date: n/a
Phase: N/A
Study type: Observational

Investigate vasoactive medicators in portal hypertension on stored sera

NCT ID: NCT00006398 Completed - Liver Cirrhosis Clinical Trials

Prevention of Esophageal Varices by Beta-Adrenergic Blockers

Start date: August 1993
Phase: Phase 3
Study type: Interventional

The purpose of this study is to learn whether timolol is useful in preventing or delaying the appearance of gastroesophageal varices, a complication that may develop in the future as a consequence of liver disease. Cirrhosis causes an increased resistance of blood flowing through the liver. This leads to an increased pressure in the portal vein (the vein that takes blood to your liver). High portal pressure is responsible for the appearance of complications of chronic liver disease such as varices and variceal bleeding (bleeding from veins in your esophagus). Timolol belongs to a group of medications called beta-blockers. Beta-blockers decrease high portal pressure and previous studies have shown that beta-blocker pills are useful in preventing bleeding from varices in patients who already have varices. A more desirable effect would be if these pills could prevent not only bleeding from varices but the appearance of varices (and therefore of bleeding).

NCT ID: NCT00004796 Completed - Cirrhosis Clinical Trials

Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis

Start date: November 1994
Phase: Phase 2
Study type: Interventional

OBJECTIVES: I. Assess the effect of lactulose on the circadian rhythm of plasma melatonin in patients with subclinical hepatic encephalopathy. II. Assess the intrasubject variability of circadian melatonin levels and neuropsychological tests. III. Assess which elements of the neuropsychological test battery show the response to lactulose.